Caplin Point Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 30-May-2025.
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Caplin Point Laboratories approved an interim dividend of ₹3.00 per equity share (150% on face value of ₹2) for FY25, with May 30, 2025 fixed as the record date to determine eligible shareholders. The company also announced its audited FY25 results, reporting consolidated total revenue of ₹2,034 Crores (up 15.5% YoY) and profit after tax of ₹541 Crores (up 17.3% YoY). EBITDA grew 20.2% to ₹743 Crores with margins improving to 36.5%, while basic EPS rose 17.2% to ₹70.57. The company ended the year with strong cash reserves — free cash reserves of ₹1,180 Crores and total liquid assets of ₹2,148 Crores. The company also appointed M/s. M Alagar & Associates as Secretarial Auditors for a five-year term starting FY26.
Positive for shareholders: The interim dividend rewards investors while the strong FY25 earnings — double-digit revenue and profit growth along with margin expansion and robust cash generation — signal healthy business momentum, likely to be viewed favorably by the market.